The FDA said that over 140,000 bottles of the Lipitor generic potentially failed to meet "dissolution specifications." ...
Nearly 142,000 bottles of atorvastatin calcium tablets recalled nationwide • Faulty dissolution may limit drug absorption and ...
PennyGem on MSN
FDA Issues Recall as 142,000 Cholesterol Bottles Flagged – 47 Million U.S. Patients Affected
Thousands of Americans who rely on cholesterol-lowering medication are now facing uncertainty after a major recall of ...
The Food and Drug Administration recalled hundreds of thousands of bottles of the cholesterol drug Atorvastatin Calcium ...
New Jersey-based Ascend Laboratories has voluntarily recalled 141,984 bottles of atorvastatin calcium, a cholesterol-lowering ...
Over 141,000 bottles of cholesterol medication have been recalled due to “failed dissolution specifications,” suggesting that ...
Ascend Laboratories, LLC, a New Jersey-based pharmaceutical company, has recalled over 141,000 bottles of cholesterol medication. An advisory from the company suggests that the drugs may have failed ...
The recall comes after the maker determined the drug may not dissolve or release its active ingredient in a way that meets ...
The FDA has recalled more than 140,000 bottles of Atorvastatin Calcium, a generic Lipitor, after tests showed some pills may ...
Articles and videos about More than 140,000 bottles of cholesterol medication recalled: See the list on KTVU FOX 2 San ...
TipRanks on MSN
Mycophenolate Pregnancy Registry: Key Insights for Investors
The study focuses on mycophenolate, a medication used primarily in organ transplantation and autoimmune diseases, to monitor pregnancy outcomes and potential birth defects. This is part of a Risk ...
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved when ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback